Historical Stock Price
ETFs Holding CRTX »    CRTX Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/30/2020 $44.96 $46.86 $44.20 $46.30 102.70K
07/01/2020 $46.26 $47.87 $46.00 $47.51 65.50K
07/02/2020 $48.00 $48.00 $45.30 $45.89 39.70K
07/06/2020 $46.69 $47.33 $45.50 $46.71 67.40K
07/07/2020 $46.51 $47.61 $46.00 $46.24 60.90K
Cortexyme is a clinical stage biopharmaceutical company focused on developing therapeutics based on data supporting a new theory of the cause of Alzheimer's disease and other degenerative disorders. Co. is targeting a specific, infectious pathogen tied to neurodegeneration and chronic inflammation in humans and animal models. Co.'s proprietary main drug candidate, COR388, is an orally administered, brain-penetrating small molecule gingipain inhibitor.
CRTX historical stock prices picture
Cortexyme (CRTX) has the following price history information. Looking back at CRTX historical stock prices for the last five trading days, on June 30, 2020, CRTX opened at $44.96, traded as high as $46.86 and as low as $44.20, and closed at $46.30. Trading volume was a total of 102.70K shares. On July 01, 2020, CRTX opened at $46.26, traded as high as $47.87 and as low as $46.00, and closed at $47.51. Trading volume was a total of 65.50K shares. On July 02, 2020, CRTX opened at $48.00, traded as high as $48.00 and as low as $45.30, and closed at $45.89. Trading volume was a total of 39.70K shares. On July 06, 2020, CRTX opened at $46.69, traded as high as $47.33 and as low as $45.50, and closed at $46.71. Trading volume was a total of 67.40K shares. On July 07, 2020, CRTX opened at $46.51, traded as high as $47.61 and as low as $46.00, and closed at $46.24. Trading volume was a total of 60.90K shares.

CRTX Historical Stock Prices By Date:

CRTX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cortexyme shares, starting with a $10,000 purchase of CRTX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/08/2010
End date: 07/07/2020
Start price/share: $5.58
End price/share: $46.24
Dividends collected/share: $0.00
Total return: 728.67%
Average Annual Total Return: 23.53%
Starting investment: $10,000.00
Ending investment: $82,837.56
Years: 10.01
Date Close
06/30/2020$46.30
07/01/2020$47.51
07/02/2020$45.89
07/06/2020$46.71
07/07/2020$46.24
CRTX is categorized under the Healthcare sector; below are some other companies in the same sector:

CRVL Historical Stock Prices
CRVS Historical Stock Prices
CRY Historical Stock Prices
CSBR Historical Stock Prices
CSII Historical Stock Prices
CSU Historical Stock Prices
CTEK Historical Stock Prices
CTH Historical Stock Prices
CTIC Historical Stock Prices
CTLT Historical Stock Prices

Also explore: CRTX shares outstanding history

CRTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.